PCVX logo

Vaxcyte, Inc. (PCVX) Cash From Operations

Annual CFO:

-$452.63M-$155.84M(-52.51%)
December 31, 2024

Summary

  • As of today, PCVX annual cash from operations is -$452.63 million, with the most recent change of -$155.84 million (-52.51%) on December 31, 2024.
  • During the last 3 years, PCVX annual cash from operations has fallen by -$331.23 million (-272.86%).
  • PCVX annual cash from operations is now -1385.68% below its all-time high of -$30.47 million, reached on December 31, 2018.

Performance

PCVX Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXcash flow metrics

Quarterly CFO:

-$143.31M-$22.14M(-18.27%)
September 30, 2025

Summary

  • As of today, PCVX quarterly cash from operations is -$143.31 million, with the most recent change of -$22.14 million (-18.27%) on September 30, 2025.
  • Over the past year, PCVX quarterly cash from operations has dropped by -$82.60 million (-136.06%).
  • PCVX quarterly cash from operations is now -1480.16% below its all-time high of -$9.07 million, reached on June 30, 2020.

Performance

PCVX Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXcash flow metrics

TTM CFO:

-$542.15M-$82.60M(-17.97%)
September 30, 2025

Summary

  • As of today, PCVX TTM cash from operations is -$542.15 million, with the most recent change of -$82.60 million (-17.97%) on September 30, 2025.
  • Over the past year, PCVX TTM cash from operations has dropped by -$72.11 million (-15.34%).
  • PCVX TTM cash from operations is now -5450.23% below its all-time high of -$9.77 million, reached on March 31, 2019.

Performance

PCVX TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

PCVX Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-52.5%-136.1%-15.3%
3Y3 Years-272.9%-271.8%-246.5%
5Y5 Years-860.1%-997.7%-955.5%

PCVX Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-272.9%at low-271.8%+13.8%-246.5%at low
5Y5-Year-870.7%at low-1230.8%+13.8%-1076.1%at low
All-TimeAll-Time-1385.7%at low-1480.2%+13.8%-5450.2%at low

PCVX Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
-$143.31M(-18.3%)
-$542.15M(-18.0%)
Jun 2025
-
-$121.17M(+27.1%)
-$459.55M(+0.0%)
Mar 2025
-
-$166.27M(-49.3%)
-$459.78M(-1.6%)
Dec 2024
-$452.63M(-52.5%)
-$111.40M(-83.5%)
-$452.63M(+3.7%)
Sep 2024
-
-$60.71M(+50.0%)
-$470.04M(-0.7%)
Jun 2024
-
-$121.39M(+23.7%)
-$466.88M(-14.4%)
Mar 2024
-
-$159.12M(-23.5%)
-$408.22M(-37.5%)
Dec 2023
-$296.79M(-74.0%)
-$128.81M(-123.8%)
-$296.79M(-27.3%)
Sep 2023
-
-$57.55M(+8.3%)
-$233.20M(-8.9%)
Jun 2023
-
-$62.74M(-31.6%)
-$214.20M(-12.4%)
Mar 2023
-
-$47.69M(+26.9%)
-$190.59M(-11.7%)
Dec 2022
-$170.60M
-$65.22M(-69.2%)
-$170.60M(-9.0%)
Sep 2022
-
-$38.55M(+1.5%)
-$156.47M(-6.9%)
Jun 2022
-
-$39.13M(-41.2%)
-$146.34M(-7.7%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$27.70M(+45.8%)
-$135.89M(-11.9%)
Dec 2021
-$121.39M(-160.3%)
-$51.09M(-79.8%)
-$121.39M(-49.7%)
Sep 2021
-
-$28.41M(+0.9%)
-$81.07M(-23.4%)
Jun 2021
-
-$28.68M(-117.2%)
-$65.71M(-42.5%)
Mar 2021
-
-$13.21M(-22.6%)
-$46.10M(+1.1%)
Dec 2020
-$46.63M(+1.1%)
-$10.77M(+17.5%)
-$46.63M(+9.2%)
Sep 2020
-
-$13.05M(-44.0%)
-$51.36M(-7.5%)
Jun 2020
-
-$9.07M(+34.0%)
-$47.77M(+8.5%)
Mar 2020
-
-$13.74M(+11.4%)
-$52.21M(-8.2%)
Dec 2019
-$47.15M(-54.7%)
-$15.50M(-63.9%)
-$48.24M(-47.4%)
Sep 2019
-
-$9.46M(+30.0%)
-$32.74M(-40.6%)
Jun 2019
-
-$13.51M(-38.3%)
-$23.28M(-138.3%)
Mar 2019
-
-$9.77M
-$9.77M
Dec 2018
-$30.47M
-
-

FAQ

  • What is Vaxcyte, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Vaxcyte, Inc.?
  • What is Vaxcyte, Inc. annual cash from operations year-on-year change?
  • What is Vaxcyte, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Vaxcyte, Inc.?
  • What is Vaxcyte, Inc. quarterly cash from operations year-on-year change?
  • What is Vaxcyte, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Vaxcyte, Inc.?
  • What is Vaxcyte, Inc. TTM cash from operations year-on-year change?

What is Vaxcyte, Inc. annual cash from operations?

The current annual cash from operations of PCVX is -$452.63M

What is the all-time high annual cash from operations for Vaxcyte, Inc.?

Vaxcyte, Inc. all-time high annual cash from operations is -$30.47M

What is Vaxcyte, Inc. annual cash from operations year-on-year change?

Over the past year, PCVX annual cash from operations has changed by -$155.84M (-52.51%)

What is Vaxcyte, Inc. quarterly cash from operations?

The current quarterly cash from operations of PCVX is -$143.31M

What is the all-time high quarterly cash from operations for Vaxcyte, Inc.?

Vaxcyte, Inc. all-time high quarterly cash from operations is -$9.07M

What is Vaxcyte, Inc. quarterly cash from operations year-on-year change?

Over the past year, PCVX quarterly cash from operations has changed by -$82.60M (-136.06%)

What is Vaxcyte, Inc. TTM cash from operations?

The current TTM cash from operations of PCVX is -$542.15M

What is the all-time high TTM cash from operations for Vaxcyte, Inc.?

Vaxcyte, Inc. all-time high TTM cash from operations is -$9.77M

What is Vaxcyte, Inc. TTM cash from operations year-on-year change?

Over the past year, PCVX TTM cash from operations has changed by -$72.11M (-15.34%)
On this page